Company Filing History:
2 out of 1,866 
2 out of 3,539 
2 out of 15,502 
Years Active: 2020-2022
Title: Alexander Julian Chatterley: Innovator in Allosteric Inhibitors
Introduction
Alexander Julian Chatterley is a notable inventor based in Pittsburgh, PA. He has made significant contributions to the field of biochemistry, particularly in the development of allosteric inhibitors. With a total of 2 patents, his work focuses on innovative methods to combat serious diseases.
Latest Patents
Chatterley's latest patents include the development of phenyl indole allosteric inhibitors of P97 ATPase. This invention is directed towards methods of inhibiting p97 and includes compounds and compositions that are useful in such methods. The diseases and conditions that can be treated with these compounds include, but are not limited to, cancer and neurodegenerative disorders that are susceptible to treatment by inhibition of p97.
Career Highlights
Throughout his career, Chatterley has worked with prestigious institutions such as the University of Pittsburgh and the National Institutes of Health, a component of the US Department of Health & Human Services. His work in these organizations has allowed him to contribute to significant advancements in medical research.
Collaborations
Chatterley has collaborated with esteemed colleagues, including Donna Mary Huryn and Peter Wipf. These partnerships have further enhanced his research and development efforts in the field of allosteric inhibitors.
Conclusion
Alexander Julian Chatterley is a prominent figure in the realm of biochemistry, with a focus on innovative treatments for serious diseases. His contributions through patents and collaborations highlight his commitment to advancing medical science.